尿氧分压作为血管紧张素II治疗脓毒症急性肾损伤时肾髓质氧合的替代指标
该干预性动物研究在16只成年美利奴母羊中建立大肠杆菌输注32小时的脓毒症急性肾损伤模型,于24-30小时输注血管紧张素II(0.5-33.0 ng/kg/min)或生理盐水对照。脓毒症时肾髓质PO2在1小时从36±1降至30±3 mm Hg、24小时降至20±2 mm Hg,尿PO2同步下降,且早于尿中性粒细胞明胶酶相关脂质运载蛋白和血清肌酐升高。血管紧张素II在脓毒症24小时恢复动脉压并改善肌酐清除率,未加重髓质或尿缺氧。作者认为尿PO2可用于检测髓质缺氧,血管紧张素II似乎安全有效。
要点
- 羊脓毒症急性肾损伤模型中,肾髓质PO2在1小时从36±1降至30±3 mm Hg、24小时降至20±2 mm Hg,尿PO2分别为42±2、34±2、23±2 mm Hg。
- 尿中性粒细胞明胶酶相关脂质运载蛋白(12%±3%)和血清肌酐(60%±23%)分别仅在8小时和24小时才检测到升高,髓质与尿缺氧早于现有生物标志物数小时出现。
- 脓毒症24小时静脉输注血管紧张素II(0.5-33.0 ng/kg/min)恢复动脉压并改善肌酐清除率,未加重髓质或尿缺氧。
- 作者认为在脓毒症急性肾损伤中血管紧张素II似乎是安全有效的治疗,尿PO2或可用于检测髓质缺氧。
适用人群与场景
- 16只成年美利奴母羊,每组8只,意识清醒状态下输注大肠杆菌32小时建立脓毒症急性肾损伤模型。
诊断标准与关键阈值
- 脓毒症急性肾损伤以低血压和肌酐清除率下降60%±6%为特征。
处置流程与药物剂量
- 脓毒症24-30小时静脉输注血管紧张素II 0.5-33.0 ng/kg/min或生理盐水对照。
研究设计与关键结果
- 干预性动物研究,16只成年美利奴母羊(每组8只),肾皮质、髓质及膀胱导管内置光纤探头测PO2,大肠杆菌输注32小时,24-30小时输注血管紧张素II(0.5-33.0 ng/kg/min)或生理盐水。
- 脓毒症时肾髓质PO2从36±1降至1小时30±3 mm Hg、24小时20±2 mm Hg,同时点尿PO2分别为42±2、34±2、23±2 mm Hg。
- 尿中性粒细胞明胶酶相关脂质运载蛋白升高12%±3%仅在8小时检测到,血清肌酐升高60%±23%仅在24小时检测到。
- 脓毒症24小时静脉输注血管紧张素II恢复动脉压并改善肌酐清除率,未加重髓质或尿缺氧。
证据类型、等级与局限
- 干预性动物研究(羊脓毒症模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为在脓毒症急性肾损伤中血管紧张素II似乎是安全有效的治疗,尿PO2或可用于检测髓质缺氧。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Angiotensin II is an emerging therapy for septic acute kidney injury, but it is unknown if its vasoconstrictor action induces renal hypoxia. We therefore examined the effects of angiotensin II on intrarenal PO2 in ovine sepsis. We also assessed the validity of urinary PO2 as a surrogate measure of medullary PO2.
DESIGN: Interventional study.
SETTING: Research Institute.
SUBJECTS: Sixteen adult Merino ewes (n = 8/group).
INTERVENTIONS: Sheep were instrumented with fiber-optic probes in the renal cortex, medulla, and within a bladder catheter to measure PO2. Conscious sheep were infused with Escherichia coli for 32 hours. At 24-30 hours, angiotensin II (0.5-33.0 ng/kg/min) or saline vehicle was infused.
MEASUREMENTS AND MAIN RESULTS: Septic acute kidney injury was characterized by hypotension and a 60% ± 6% decrease in creatinine clearance. During sepsis, medullary PO2 decreased from 36 ± 1 to 30 ± 3 mm Hg after 1 hour and to 20 ± 2 mm Hg after 24 hours; at these times, urinary PO2 was 42 ± 2, 34 ± 2, and 23 ± 2 mm Hg. Increases in urinary neutrophil gelatinase-associated lipocalin (12% ± 3%) and serum creatinine (60% ± 23%) were only detected at 8 and 24 hours, respectively. IV infusion of angiotensin II, at 24 hours of sepsis, restored arterial pressure and improved creatinine clearance, while not exacerbating medullary or urinary hypoxia.
CONCLUSIONS: In septic acute kidney injury, renal medullary and urinary hypoxia developed several hours before increases in currently used biomarkers. Angiotensin II transiently improved renal function without worsening medullary hypoxia. In septic acute kidney injury, angiotensin II appears to be a safe, effective therapy, and urinary PO2 may be used to detect medullary hypoxia.
参考来源
- Lankadeva YR, Kosaka J, Evans RG, et al. Urinary Oxygenation as a Surrogate Measure of Medullary Oxygenation During Angiotensin II Therapy in Septic Acute Kidney Injury. Crit Care Med. 2018. PMID: 29077618. doi:10.1097/CCM.0000000000002797
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。